Suchergebnisse - (Person:"Wagner, Kathryn R")

PubPharm (33)

1

The state of the field : myology

enthalten in: Current opinion in neurology | 2009

von Wagner, K.

2

Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice

enthalten in: Human molecular genetics | 2009

von Sumner, C. | Wee, C. | Warsing, L. | +4

3

A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis

enthalten in: Experimental neurology | 2009

von Morrison, B. | Lachey, J. | Warsing, L. | +10

4

A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis

enthalten in: Experimental neurology | 2009

von Morrison, B. | Lachey, J. | Warsing, L. | +10

5

The need for biomarkers in amyotrophic lateral sclerosis drug development

enthalten in: Neurology | 2009

von Wagner, K.

CommentOn: Neurology. 2009 Jan 6;72(1):14-9. - PMID 18987350

6

The need for biomarkers in amyotrophic lateral sclerosis drug development

enthalten in: Neurology | 2009

von Wagner, K.

7

A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis

enthalten in: Experimental neurology | 2009

von Morrison, B. | Lachey, J. | Warsing, L. | +10

8

Approaching a new age in Duchenne muscular dystrophy treatment

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2008

von Wagner, K.

9

Approaching a new age in Duchenne muscular dystrophy treatment

enthalten in: Neurotherapeutics | 2008

von Wagner, K.

10

Approaching a new age in Duchenne muscular dystrophy treatment

enthalten in: Neurotherapeutics | 2008

von Wagner, K.